Myelodysplastic syndrome resembling chronic myeloproliferative disorders in clinicopathological aspects

International Journal of Hematology

Volumn 68, Issue 1, 1998, Pages 79-85

  Fukuda, Shunichi ^a   Nagai, Hiroshi ^a   Kotani, Shigemitsu ^a   Sezaki, Tatsuo ^a   Murakami, Motomasa ^a   Kitajima, Koichi ^b   Sanada, Hiroshi ^b  

^a National Hospital Organization   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Chronic myeloproliferative disorder; Myelodysplastic syndrome; Myelofibrosis; Thrombocytosis

Indexed keywords

AGED; ARTICLE; BLAST TRANSFORMATION; BONE MARROW CELL; CASE REPORT; CHROMOSOME ABERRATION; CHRONIC DISEASE; HISTOPATHOLOGY; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; PRIORITY JOURNAL; STEM CELL; THROMBOCYTOPENIA; THROMBOCYTOSIS;

EID: 0032125906     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(98)00037-1     Document Type: Article

References (17)

1. Bennett JM, Catovsky D, Daniel MT et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 51:1982;189-199.
2. Ohyashiki K, Yokoyama K, Kimura Y et al. Myelodysplastic syndrome evolving into a myeloproliferative disorder: one disease or two? Leukemia. 7:1993;338-340.
3. Sultan C, Sigaux F, Imbert M, Reyes F. Acute myelodysplaia with myelofibrosis: a report of eight cases. Br J Haematol. 49:1981;11-16.
4. Lambertenghi-Deliliers G, Orazi A, Luksch R, Annaloro C, Soligo D. Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity. Br J Haematol. 78:1991;161-166.
5. Maschek H, Georgii A, Kaloutsi V et al. Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients. Eur J Haematol. 48:1992;208-214.
6. Imbert M, Nguyen D, Sultan C. Myelodysplastic syndromes (MDS) and acute myeloid leukemias (AML) with myelofibrosis. Leuk Res. 16:1992;51-54.
7. Pagliuca A, Layton DM, Manoharan A, Gordon S, Green PJ, Mufti GJ. Myelofibrosis in primary myelodysplastic syndromes: a clinico-morphological study of 10 cases. Br J Haematol. 71:1989;499-504.
8. Takahashi M, Koike T, Nagayama R et al. Myelodysplastic syndrome with myelofibrosis: myelodysplastic syndromes as a major primary disorder for acute myelofibrosis. Clin Lab Haematol. 13:1991;17-23.
9. Kimura K, Yamada I, Uzuka Y et al. Phase II study of SM-108 (4-Carbamoylimidazolium-5-olate) on hematological malignancies. Jpn J Cancer Chemother. 16:1989;123-130.
10. Dameshek W. Some speculation on the myeloproliferative syndromes. B1ood 1951;6:372-375.
11. Cunningham I, MacCallum SJ, Nicholls MD, Byth K, Hewson JW, Arnold B, Motum PI, Mulligan SP, Crane GG. The myelodysplastic syndromes; an analysis of prognostic factors in 226 cases from a single institution. Br J Haematol. 90:1995;602-606.
12. Lambertenghi-Deliliers G, Annnaloro C, Oriani A, Soligo D, Pozzoli E, Polli EE. Prognostic relevance of histological findings on bone marrow biopsy in myelodysplastic syndromes. Ann Haematol. 66:1993;85-91.
13. Rios A, Canizo MC, Sanz MA et al. Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors. Br J Haematol. 75:1990;26-33.
14. Kitagawa M, Kamiyama R, Takemura T, Kasuga T. Bone marrow analysis of the myelodysplastic syndromes: histological and immunohistochemical features related to the evolution of overt leukemia. Virchows Archiv B Cell Pathol. 57:1989;47-53.
15. Relly JT, Barnett D, Dolan G, Forrest P, Eastham J, Smith A. Characterization of an acute micromegakaryocytic leukemia; evidence for the pathogenesis of myelofibrosis. Br J Haemato1. 83:1993;58-62.
16. Suciu S, Kuse R, Weh HJ, Hossfeld DK. Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome. Cancer Genet Cytogenet. 44:1990;15-26.
17. Sato Y, Suto Y, Pietenpol J et al. TEL and KIPI define the smallest region of deletion on 12p13 in hematopoietic malignancies. Blood. 86:1995;1525-1533.